*Organism (including strain): Leishmania major strain Friedlin
Etiologic Risk Group (see link below): Leishmania is a protozoan and its parasite reposible for the disease leishmaniasis. It is spread to humans though bloodsucking sand flies. The symptoms of leishmaniasis are skin sores, which erupt weeks to months after a person is affected. The infection include fever, damage to the spleen and liver and anemia. Essentiality of this protein: LmjF30.0380 has essentiality data
Gene/Ortholog: Tb927.6.1800 (OG4_19717); Phenotype: significant loss of fitness in bloodstream forms (3 days); Source study: alsford
Gene/Ortholog: Tb927.6.1800 (OG4_19717); Phenotype: no significant loss or gain of fitness in bloodstream forms (6 days); Source study: alsford
Gene/Ortholog: Tb927.6.1800 (OG4_19717); Phenotype: no significant loss or gain of fitness in procyclic forms; Source study: alsford
Gene/Ortholog: Tb927.6.1800 (OG4_19717); Phenotype: significant loss of fitness in differentiation of procyclic to bloodstream forms; Source study: alsford
Expression Information (has it been expressed in bacterial cells):Escherichia coli
Purification Method:Purification is accomplished by ammonium sulfate fractionation, Sephadex G-75 chromatography, affinity chromatography on Amicon Matrex Gel Orange A and chromatofocusing.
Image of protein (PyMol with features delineated and shown separately):
*NCBI Gene:XP_001685487.1
*Protein ID: 1A6Q, LmjF30.0380
*Organism (including strain): Leishmania major strain Friedlin
Etiologic Risk Group (see link below):
Leishmania is a protozoan and its parasite reposible for the disease leishmaniasis. It is spread to humans though bloodsucking sand flies. The symptoms of leishmaniasis are skin sores, which erupt weeks to months after a person is affected. The infection include fever, damage to the spleen and liver and anemia.
Essentiality of this protein:
LmjF30.0380 has essentiality data
Gene/Ortholog: Tb927.6.1800 (OG4_19717); Phenotype: significant loss of fitness in bloodstream forms (3 days); Source study: alsford
Gene/Ortholog: Tb927.6.1800 (OG4_19717); Phenotype: no significant loss or gain of fitness in bloodstream forms (6 days); Source study: alsford
Gene/Ortholog: Tb927.6.1800 (OG4_19717); Phenotype: no significant loss or gain of fitness in procyclic forms; Source study: alsford
Gene/Ortholog: Tb927.6.1800 (OG4_19717); Phenotype: significant loss of fitness in differentiation of procyclic to bloodstream forms; Source study: alsford
Complex of proteins?:1
Druggable Target:yes
*EC#:3.1.3.16
Link to BRENDA EC# page: http://www.brenda-enzymes.org/php/result_flat.php4?ecno=3.1.3.16
Enzyme Assay information (spectrophotometric, coupled assay ?, reagents):
http://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Enzyme_Assay/calcineurin.pdf
http://iai.asm.org/content/75/5/2136
http://www.biomedcentral.com/1471-2164/8/434
http://www.ncbi.nlm.nih.gov/pubmed/10722732
-- List cost and quantity of substrate reagents and supplier
Structure Available (PDB or Homology model)
http://www.pdb.org/pdb/explore/explore.do?pdbId=1a6q
PDB#: 1A6Q
Current Inhibitors: none
Expression Information (has it been expressed in bacterial cells): Escherichia coli
Purification Method:Purification is accomplished by ammonium sulfate fractionation, Sephadex G-75 chromatography, affinity chromatography on Amicon Matrex Gel Orange A and chromatofocusing.
Image of protein (PyMol with features delineated and shown separately):
amino acid sequence:
MGLMLPKPILSKVVDRAGNSFVNAACASQNGFRNSMEDAHMLVATDDADVAYFGIFDGHSNAECSAYVARELPQRLKKLPESITAEMLEKVCIEVDEAYMKTSTEGGTTGTFCVIRKDLTVTIANVGDSRILVCRGGKLIFATEDHKPYIPGETERIVACGGSVVSNRVDGDLAVSRAFGDASFKVKGTKDYRMQKVIAVPDVSVLQCEPNDFIILACDGVFEGNFSNEDVCQFVWEQQQNCWDDLAVVACRVCDEAIRCGSKDNISCLVVQLAEGASRVKAFGATSFVPGPPFPRNQQPCRAAYAQMAELGHTTTAAALQTRYQLLQAFSKNKLNSQPPVMRTAFEMSDEVDVETEWSFFGKGPAPGNEKNFFEALANTGNSS
Number of amino acids: 384
Molecular weight: 41732.2
Theoretical pI: 4.97
*GC% Content for gene:
*CDS Gene Sequence (codon optimized) - copy from output of Primer Design Protocol (paste as text only):
*GC% Content for gene (codon optimized):
Resources:
See ProtocolTargetDiscoveryVDS.docx for more
Etiologic Risk Group Categories (for pathogens):http://www.utexas.edu/research/rsc/ibc/agent_class.html#_Toc7238334
Databases of genes/organisms:
http://www.niaid.nih.gov/Pages/default.aspx
http://eupathdb.org/eupathdb/
https://patricbrc.vbi.vt.edu/portal/portal/patric/Home
http://www.nmpdr.org/FIG/wiki/view.cgi/Main/EssentialGenes
http://tubic.tju.edu.cn/deg/
http://csgid.org/csgid/cake/pages/community_request_gateway
http://tdrtargets.org/
http://gsc.jcvi.org/status.shtml